DDL logo
Menu
  • The Aerosol Society logo
DDL logo
  • DDL2021
    • New Researcher Network
    • Media Partners
  • Archive
    • Conference Papers Archive
    • DDL2020
      • Conference Papers
      • Speakers
      • Sponsors
    • DDL2019
      • Conference Papers
      • Speakers
      • Sponsors
    • DDL2018
      • Conference Papers
      • Speakers
      • Sponsors
    • DDL2017
      • Conference Papers
      • Speakers
      • Sponsors
    • DDL2016
      • Conference Papers
      • Speakers
      • Sponsors
    • DDL2015
      • Conference Papers
    • Previous Years
  • DDL Annual Lecture
  • Awards & Grants
    • DDL Career Development Grant
    • The DDL Emerging Scientist Award
    • The Pat Burnell Young Investigator Award
  • About
    • History
    • DDL Charter
    • Committee
    • Scientific Advisors
  • External Events
    • 2021 ISAM Congress
    • RDD 2021
  • Contact
  • The Aerosol Society logo
loading...

Andy Cooper :

Andy Cooper

Research specialist, Kindeva Drug Delivery

Paper: In silico modelling of regional lung deposition for metered dose and soft mist inhalers

Download Paper

Andy is a research specialist at Kindeva Drug Delivery, a pharmaceutical contract development and manufacturing organization (CDMO). In this role, he is responsible for driving new ideas and providing broad subject matter expertise to resolve critical issues during complex inhalation product development. He has nearly 20 years of experience within the inhalation field.
Andy represents Kindeva on multiple sub-teams of the European Pharmaceutical Aerosol Group (EPAG), has contributed to several peer-reviewed publications and is the Industrial Advisory Board chair for the School of Science at Loughborough University.
He is a Chartered Chemist within the RSC, and holds a BSc in Medicinal Chemistry from UMIST.

Video of Andy Cooper

  • Terms
  • Privacy & Cookie policy
  • Contact
  • Committee

© 2021 Drug Delivery to the Lungs Website design: definingdesign.co.uk